Vistagen (VTGN): Long-term Game-changer
Updated
*This is not financial advice. This is my non-expert opinion.*
Vistagen (
VTGN) is a clinical stage biopharmaceutical company with long-term potential. I believe it's technology is similarly game-changing the way I believe NanoFlu for Novavax is (novavax.com/our-pipeline (
NVAX). It could have positive outcomes for the world. I hope that their tech comes to fruition. Their pipeline includes Neuroactive nasal sprays that don't involve benzodiazepine and its associated side effects. I hope they succeed because it could change the way patients with anxiety or depression-related disorders are treated.
Vistagen: https://www.vistagen.com/about
Pipeline: https://www.vistagen.com/pipeline
PH94B Neuroactive Nasal Spray is their most advanced candidate, which is currently in Stage 3 clinical trials. I encourage anyone who wants to do their own research. This animated demonstration was very informative for me https://www.youtube.com/watch?v=YC4pnAySd80
Keep an eye out for this company.
Vistagen (
VTGN) is a clinical stage biopharmaceutical company with long-term potential. I believe it's technology is similarly game-changing the way I believe NanoFlu for Novavax is (novavax.com/our-pipeline (NVAX). It could have positive outcomes for the world. I hope that their tech comes to fruition. Their pipeline includes Neuroactive nasal sprays that don't involve benzodiazepine and its associated side effects. I hope they succeed because it could change the way patients with anxiety or depression-related disorders are treated.Vistagen: https://www.vistagen.com/about
Pipeline: https://www.vistagen.com/pipeline
PH94B Neuroactive Nasal Spray is their most advanced candidate, which is currently in Stage 3 clinical trials. I encourage anyone who wants to do their own research. This animated demonstration was very informative for me https://www.youtube.com/watch?v=YC4pnAySd80
Keep an eye out for this company.
Note
To clarify, the above earnings date is ESTIMATED.Source: marketbeat.com/stocks/NASDAQ/VTGN/earnings/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.